RecruitingNot Applicable

BioBrace® Augmentation in Anterior Cruciate Ligament Reconstruction Procedures

United States500 participantsStarted 2025-04-08

Plain-language summary

This research study will evaluate mid-term clinical safety and performance outcomes of the BioBrace® Reinforced Implant when used to augment a tissue graft during anterior cruciate ligament (ACL) reconstruction.

Who can participate

Age range14 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Underwent ACL reconstruction with a tissue graft augmented with BioBrace® within the past 24 months from study start date or scheduled to undergo ACL reconstruction with a tissue graft augmented with BioBrace®.
✓. Between 14 and 70 years old at the time of surgery.
✓. Can understand the content of the subject information / Informed Consent Form (ICF) for the prospective portion of the study.
✓. Is willing and able to participate in the prospective data collection protocol and comply with the required data collection.
✓. If the subject has already undergone ACLR within the past 24 months, subject must have at least two (2) of the following measures at baseline and 1 year post-operatively:
✓. International Knee Documentation Committee (IKDC)
✓. Knee Injury and Osteoarthritis Outcome Score Junior (KOOS, JR.)
✓. Patient-Reported Outcomes Measurement Information System (PROMIS-10)

Exclusion criteria

✕. Has other concurrent medical or other conditions (chronic or acute in nature) that in the opinion of the participating investigator may prevent participation or otherwise render subject ineligible for the study.
✕. Is currently participating in an investigational therapy (device and/or pharmaceutical) within 30 days prior to entering the study or such treatment is planned during the 3 years following enrollment into the study.
✕. Underwent or scheduled to undergo a multi-ligament reconstruction procedure (excluding cases where a torn MCL is treated non-operatively).
✕. Females of child-bearing potential who are either pregnant or breastfeeding at the time of surgery.

What they're measuring

Improvement in Function

Timeframe: 3 years post-op

Adverse Events

Timeframe: Baseline, 6-months, 1-, 2-, and 3-years post-op

Trial details

NCT IDNCT06948591

SponsorCONMED Corporation

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2030-06

Contact for this trial

Kelley Grynewicz

7274574955 ClinicalAffairs@conmed.com

View on ClinicalTrials.gov More ACL Tears trials